Abstract: Disclosed are a low-cost high-efficiency drip irrigation system for a cotton field and a use method thereof. The drip irrigation system for a cotton field includes a filtering device and a water supply device; wherein the filtering device adopts different types of single filtering devices or combined filtering devices according to different water source types; the water supply device includes multiple stages of main pipes, submain pipes and laterals; the laterals (a drip irrigation tape with labyrinth on one side or a drip irrigation tape inlaid with emitters inside) are laid on the surface of the ground and located below a mulch film. The drip irrigation system adopts the design of large flow (1.5-3.4 L/h), slightly larger pipe diameter (>75 mm), low water pressure (operating pressure of drip irrigation tape being 0.03-0.07 MPa) and suitable drip irrigation uniformity (80%-90%).

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed is an active control Stewart vibration damping platform, including a load-bearing platform, a base, and six telescopic rods. Each telescopic rod includes a driving motor, a rotating shaft, a sleeve, and a moving rod. One end, away from the driving motor, of the rotating shaft is provided with a cylindrical cavity, one end of the moving rod penetrates through the cylindrical cavity, and the sleeve is sleeved outside the rotating shaft. The rotating shaft is in running fit with the sleeve through a first bearing, and the moving rod is in sliding fit with the sleeve through a second bearing. The moving rod and the rotating shaft are respectively provided with a spiral permanent magnet. The spiral permanent magnet on the rotating shaft can drive the moving rod to move in an axial direction of the rotating shaft through the spiral permanent magnet on the moving rod when rotating.

Abstract: A crystal form of a pyridinylphenyl compound and a preparation method therefor. Use of the crystal form in the preparation of a medicament of treating related diseases is also comprised.

Abstract: Provided is a call response method in the field of terminal technology. The call response method includes receiving a first call indication message and a second call indication message sent by a network device, determining a target state of the terminal device, and responding to the first call indication message or the second call indication message according to the target state to perform the PS call or the CS call.

Abstract: A crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound and a preparation method therefor. Also provided is an application of the crystal form in the preparation of a medicine for treating related diseases.

Abstract: A vaporizer is disclosed. The vaporizer includes a liquid storage housing having a liquid storage cavity formed therein and a base arranged at one end of the liquid storage housing. The base includes an air inlet protruding stage that has an upper surface facing the liquid storage cavity. The upper surface is in a shape of a protrusion. The air inlet protruding stage is provided with a plurality of air inlet holes extending from the upper surface away from the liquid storage cavity.

Abstract: An aminopyridine compound that may be used as an aldehyde trapping agent, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: A crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound and a preparation method therefor. Also provided is an application of the crystal form in the preparation of a medicine for treating related diseases.

Abstract: The present invention relates to a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt thereof, and relates to applications thereof in the preparation of drugs for treating FXR related diseases.

Abstract: The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a composition comprising a compound as shown in formula (I) and a preparation method therefor, and the use of same in the preparation of a drug for treating ophthalmic diseases.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Disclosed are a process route of a compound of a compound of formula (IV), a crystal form and a preparation method therefor. Also disclosed is an application of the crystal form in preparation of drugs for treating diseases associated with SSAO.

Abstract: Implementations of the present specification disclose a method, an apparatus, and a device for processing a web application package. In the method, processing the web application package includes: determining a resource required by a web application; storing the resource; determining a resource address corresponding to a storage location of the resource; and generating a web application package that comprises the resource address, wherein the web application package excludes the resource corresponding to the resource address.

Abstract: The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease.

Abstract: The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease.

Abstract: The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.